Qiming Venture Partners' portfolio company LanzaTech Lists on Nasdaq
/PRNewswire/ -- LanzaTech NZ, Inc. ("LanzaTech"), an innovative leader in carbon capture and transformation and a Qiming Venture Partners portfolio company,...
Stay updated with breaking news from Venus Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- LanzaTech NZ, Inc. ("LanzaTech"), an innovative leader in carbon capture and transformation and a Qiming Venture Partners portfolio company,...
/PRNewswire/ -- On Feb 9 Beijing time, Hesai Technology ("Hesai"), a global leader in LiDAR technology and Qiming Venture Partners' portfolio company, began...
/PRNewswire/ -- Qiming Venture Partners' portfolio company Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical stage global biopharmaceutical company...
The global Transcatheter Aortic Valve System market is expected grow at a CAGR of 11% between 2023 to 2032.What is the Transcatheter Aortic Valve system?Aortic stenosis is a condition when the aortic valve somehow doesn’t fully open, prompting blood circulation to be restricted. A huge artery called the aorta delive...
Investegate announcements from JPMorgan China G&I, Annual Financial Report